26/06/2026
π’ **In the News | Dr Suzanne Wylie featured in Metro**
We're pleased to see **Dr Suzanne Wylie, Clinical Advisor to iQ Doctor**, featured in Metro discussing the growing conversation around so-called *"Ozempic Butt"* and new research that could help preserve muscle mass during weight loss treatment.
As the use of GLP-1 medications such as Wegovy and Mounjaro continues to grow, there is increasing recognition that successful weight loss isn't just about the number on the scales. Preserving muscle mass is equally important for long-term health, physical strength and metabolic wellbeing. Studies suggest that some lean body mass can be lost alongside fat during significant weight loss, which is why nutrition, protein intake and resistance exercise remain important parts of the journey.
The emerging research highlighted by Metro explores whether future treatments could help protect muscle while people lose weight, potentially improving outcomes for patients using GLP-1 medications.
At iQ Doctor, we're passionate about supporting patients with evidence-based, clinically led care that looks beyond weight loss alone and focuses on overall health, strength and wellbeing.
Read the Metro article here:
https://metro.co.uk/2026/06/10/weight-loss-jabs-linked-ozempic-butt-a-new-drug-might-stop-28711445/
π
Doctors have warned it could impact overall health.